YG

Yojna Goyal

Active Director Director DIN 03337414
DIN 03337414 First appointment Dec 2010 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2010
Shareholding value •••• Premium profile

About Yojna Goyal

Data last updated:

Yojna Goyal is a Director at Kanak Pharma Private Limited (since 2010). The company operates in Trading. Kanak Pharma Private Limited reported revenue of ₹4.45 Cr (FY 2025).

DIN 03337414
Primary Designation Director
Industry Trading
First Appointment 16 Dec 2010
Oldest Company Age 15 yrs
Largest company Kanak Pharma Private Limited · ₹4.45 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kanak Pharma Private Limited U85191UP2010PTC042852
Director16 Dec 20102010₹4.45 Cr (FY 2025)Active

Board colleagues of Yojna Goyal

NameDINCompanyDesignation
Anoop Kumar Goyal03337405Kanak Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kanak Pharma Private Limited
Premium access

Shareholding and investment profile for Yojna Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yojna Goyal

Yojna Goyal currently holds 1 directorship: Kanak Pharma Private Limited (Director, since 16 Dec 2010, revenue ₹4.45 Cr (FY 2025)).

Yojna Goyal was first appointed on 16 Dec 2010 as Director at Kanak Pharma Private Limited.

The current boards of Yojna Goyal's companies include Anoop Kumar Goyal (Kanak Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available